TAP2, another SMR gene, localises to the MHC class II region and plays a pivotal role in immune surveillance, with polymorphisms linked to the susceptibility of various autoimmune disorders [34–36] and various neoplasms [37–39]. The gene discussed is LYPD4; the disease is neoplasm.